GHK-Cu, also known as copper peptide GHK-Cu or glycyl-L-histidyl-L-lysine copper complex, is a naturally occurring tripeptide-copper chelate that has been the subject of extensive preclinical investigation. First identified in human plasma in the 1970s by Dr. Loren Pickart, GHK-Cu has since been studied for its involvement in a wide range of biological processes at the molecular level, including gene expression modulation, extracellular matrix remodeling, and antioxidant defense signaling.
Structure and Copper Binding
GHK-Cu consists of three amino acids, glycine, histidine, and lysine, arranged in a linear sequence with a molecular weight of approximately 403.9 Daltons in its copper-bound form. The histidine residue provides the primary coordination site for the copper(II) ion through its imidazole nitrogen, while additional coordination is provided by the peptide backbone amide nitrogen and the terminal amino group. This high-affinity copper binding is central to the biological activity observed in preclinical studies.
Copper ions are essential cofactors for numerous enzymes involved in connective tissue formation, antioxidant defense, and cellular respiration. The GHK peptide sequence has a strong affinity for copper(II), and the resulting complex has been proposed to function as a physiological copper delivery system, transporting copper to cells and tissues where it is needed for enzymatic function.
Gene Expression Research
One of the most notable findings in GHK-Cu research emerged from gene expression profiling studies conducted using the Broad Institute Connectivity Map database. These computational analyses identified GHK as a compound capable of modulating the expression of a large number of human genes. Researchers reported that GHK-Cu influenced the expression of genes involved in multiple pathways, including those related to extracellular matrix components, antioxidant enzymes, ubiquitin-proteasome activity, and DNA repair mechanisms.
In-vitro studies using human fibroblast and keratinocyte cell cultures have examined how GHK-Cu affects the production of collagen, elastin, glycosaminoglycans, and other extracellular matrix components. These cell culture experiments have generally reported increased synthesis of collagen types I and III and increased production of decorin and other matrix proteoglycans in GHK-Cu-treated cultures compared to controls.
Antioxidant and Anti-Inflammatory Research
Preclinical studies have investigated the antioxidant properties of GHK-Cu through several proposed mechanisms. The copper ion in the complex serves as a cofactor for superoxide dismutase (SOD), a critical antioxidant enzyme. Additionally, in-vitro studies have reported that GHK-Cu can reduce the formation of reactive carbonyl species and lipid peroxidation products in cell culture models of oxidative stress.
Research into the anti-inflammatory properties of GHK-Cu has been conducted in cell culture systems and animal models. Studies have reported modulation of inflammatory cytokine expression, including reductions in interleukin-6 and tumor necrosis factor-alpha in treated cell cultures. These observations have generated interest in GHK-Cu as a research tool for studying the relationship between copper homeostasis and inflammatory signaling.
Dosage Forms in Research
GHK-Cu is available in multiple forms for different research applications. For in-vitro cell culture studies, it is commonly dissolved in aqueous buffer at micromolar concentrations. For topical application research, it has been formulated in cream and serum preparations at concentrations typically ranging from 0.01% to 1%. Injectable formulations using lyophilized powder reconstituted in bacteriostatic water have been used in animal model studies.
The lyophilized powder form is the most versatile for research purposes, as it allows precise preparation of solutions at defined concentrations. GHK-Cu is readily soluble in water and most aqueous buffers at physiological pH. Researchers should note that copper peptide solutions may have a faint blue color due to the copper(II) ion, which is normal and does not indicate degradation.
Storage and Stability
Lyophilized GHK-Cu should be stored at negative twenty degrees Celsius for long-term stability, where it remains viable for twelve months or longer. Reconstituted solutions should be refrigerated at two to eight degrees Celsius and used within two to four weeks. GHK-Cu is sensitive to strong reducing agents, which can reduce the copper(II) to copper(I) and alter the biological activity of the complex. Researchers should ensure that buffers used for reconstitution do not contain high concentrations of reducing agents such as dithiothreitol or beta-mercaptoethanol.
Research Use Notice
GHK-Cu is provided as a research chemical for in-vitro and preclinical investigation only. It is not approved for therapeutic use in humans or animals. All data discussed in this article derives from preclinical studies and should not be interpreted as evidence of clinical efficacy. Researchers are responsible for compliance with all applicable institutional and regulatory guidelines.